Delta Chase, LLC is a research and development company that is designing the SAGE Rebreather, a novel multi-modal platform medical device intended to safely elevate the body's carbon dioxide levels. The device is being developed to treat and alleviate conditions such as sleep apnea, altitude illness, and brain injuries, though its claims have not yet been authorized by the FDA.
Subscribe to see DELTA CHASE, LLC’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
DELTA CHASE, LLC is a medical devices company headquartered in United States. It has raised at least $10.2M across the 3 funding rounds on record. Its most recent funding round raised $5M in August 2025. Xcout tracks 7 named people at DELTA CHASE, LLC, including Neil Kosterman (Manager and COO of Issuer).
1 more named person on record for DELTA CHASE, LLC, with roles, board committees and tenure — see the full roster →
At least $10.2M raised across the 3 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $5M | — | |
| SEC Form D filing | $150,000 | — | |
| SEC Form D filing | $5M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of DELTA CHASE, LLC's closest competitors — see the full list of competitors and alternatives →
Rapid Oxygen Co., LLC, led by CEO Richard Imbruce and based in Brooklyn, New York, is commercializing safe portable chemical oxygen delivery systems.
RTM Vital Signs LLC is a medical device company that develops wearable, AI-enabled monitoring systems for continuous real-time tracking of respiratory and cardiac function. Its products, such as RTMsense, are designed to help hospitals and healthcare providers proactively detect respiratory compromise and prevent events like opioid-induced respiratory depression.
Cadence Biomedical, Inc. is an early-stage medical device company headquartered in Seattle, Washington, focused on developing healthcare technologies to help patients.
Lunair Medical is developing an implantable neurostimulation device and connected digital platform designed to treat moderate-to-severe sleep apnea. The system utilizes closed-loop phrenic nerve stimulation and respiration sensing to maintain an open airway during sleep without the use of masks or wearables.
REMSleep Holdings, Inc. is an enterprise globally focused on crafting and providing solutions for individuals afflicted with sleep apnea. Among its key offerings is the DeltaWave CPAP interface device, specifically engineered to aid in the treatment of patients suffering from this condition. The company caters to a broad spectrum of clients, including home healthcare providers, independent sleep clinics, direct consumers, medical practitioners, group medical organizations, hospitals, and various professional medical associations. Its corporate headquarters are situated in Tampa, Florida.
ALung Technologies develops extracorporeal respiratory support devices, including the Hemolung Respiratory Assist System, designed to remove carbon dioxide from blood and support patients with acute respiratory failure. Its products are intended for hospitals and critical-care clinicians treating patients who need respiratory support, including certain patients with severe COPD or who may otherwise require mechanical ventilation.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.